These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 4132893)
1. Use of plasma levels in evaluation of procainamide dosage. Shaw TR; Kumana CR; Royds RB; Padgham CM; Hamer J Br Heart J; 1974 Mar; 36(3):265-70. PubMed ID: 4132893 [No Abstract] [Full Text] [Related]
2. Incidence and management of ventricular arrhythmias after acute myocardial infarction. Raftery EB; Rehman MF; Banks DC; Oram S Br Heart J; 1969 May; 31(3):273-80. PubMed ID: 4100820 [No Abstract] [Full Text] [Related]
3. Lidocaine (Xylocaine) as an anti-arrhythmic agent. Med Lett Drugs Ther; 1971 Jan; 13(1):1-2. PubMed ID: 4104507 [No Abstract] [Full Text] [Related]
4. Plasma levels of procaine amide after administration of conventional and sustained-release tablets. Karlsson E Eur J Clin Pharmacol; 1973 Dec; 6(4):245-50. PubMed ID: 4591151 [No Abstract] [Full Text] [Related]
5. [Therapy of arrhythmias]. Hartl O; Clodi PH Wien Z Inn Med; 1973; 54(8-9):384-98. PubMed ID: 4139823 [No Abstract] [Full Text] [Related]
6. [Tachyarrhythmias caused by acute myocardial infarct]. Popescu PN; Mihail A Med Interna (Bucur); 1970 Dec; 22(12):1443-50. PubMed ID: 4100622 [No Abstract] [Full Text] [Related]
7. [Oral administration of procainamide for ventricular arrhythmia. Plasma concentrations during use of tablets(Pronestyl) and a slow-release preparation (Porcainamide Durettes)]. Bliddal J Ugeskr Laeger; 1976 Sep; 138(40):2425-33. PubMed ID: 968996 [No Abstract] [Full Text] [Related]
8. Bretylium tosylate in treatment of refractory ventricular arrhythmias complicating myocardial infarction. Terry G; Vellani CW; Higgins MR; Doig A Br Heart J; 1970 Jan; 32(1):21-5. PubMed ID: 5417842 [No Abstract] [Full Text] [Related]
9. Comparison of drugs used in management of arrhythmias developing after acute myocardial infarction. Jewitt DE; Mercer CJ; Hubner PJ; Shillingford JP Br Heart J; 1969 Nov; 31(6):794. PubMed ID: 5358169 [No Abstract] [Full Text] [Related]
10. Antiarrhythmic prophylaxis with procainamide in acute myocardial infarction. Koch-Weser J; Klein SW; Foo-Canto LL; Kastor JA; DeSanctis RW N Engl J Med; 1969 Dec; 281(23):1253-60. PubMed ID: 4900236 [No Abstract] [Full Text] [Related]
11. Comparison of procainamide and mexiletine in prevention of ventricular arrhythmias after acute myocardial infarction. Campbell RW; Dolder MA; Prescott LF; Talbot RG; Murray A; Julian DG Lancet; 1975 Jun; 1(7919):1257-60. PubMed ID: 48894 [TBL] [Abstract][Full Text] [Related]
12. [Anti-arrhythmia agents]. Kaufmann G Med Klin; 1974 May; 69(18):778-86. PubMed ID: 4134645 [No Abstract] [Full Text] [Related]
18. Effect of procainamide and lidocaine on total electrical systole of ventricular premature depolarizations. Giardina EG; Bigger JT Am J Med; 1975 Sep; 59(3):405-10. PubMed ID: 1163548 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive treatment plan for the prevention of primary ventricular fibrillation in acute myocardial infarction. Wyman MG; Hammersmith L Am J Cardiol; 1974 May; 33(5):661-7. PubMed ID: 4820897 [No Abstract] [Full Text] [Related]
20. Comparative antiarrhythmic effects of intravenously administered lidocaine and procainamide and orally administered quinidine. Schwartz ML; Webb NC; Covino BG; Finck EM; Haider B Am J Cardiol; 1970 Nov; 26(5):520-3. PubMed ID: 4097888 [No Abstract] [Full Text] [Related] [Next] [New Search]